Dean W. Hum

机构：Genfit (France)

发表论文 123 篇 · 总被引 8420 次 · h-index 45

代表论文

• Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening (2016 · Gastroenterology · 被引 1031)
• Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (2013 · Hepatology · 被引 412)
• Safety issues and prospects for future generations of PPAR modulators (2007 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 被引 311)
• A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study (2020 · ˜The œLancet. Gastroenterology & hepatology · 被引 256)
• Does endoplasmic reticulum stress participate in APD-induced hepatic metabolic dysregulation? (2011 · Neuropharmacology · 被引 79)
• Phosphorylation of Farnesoid X Receptor by Protein Kinase C Promotes Its Transcriptional Activity (2008 · Molecular Endocrinology · 被引 78)